Catalyst Pharmaceuticals Total Shareholders Equity 2011-2026 | CPRX

Annual Total Shareholders Equity Catalyst Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
954 M	728 M	388 M	300 M	207 M	170 M	87.6 M	50.8 M	81 M	39.3 M	55.5 M	35.2 M	21.4 M	14.6 M	3.76 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
954 M	3.76 M	209 M

Quarterly Total Shareholders Equity Catalyst Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
920 M	856 M	794 M	728 M	661 M	609 M	561 M	388 M	349 M	375 M	334 M	300 M	270 M	241 M	220 M	207 M	199 M	189 M	179 M	170 M	170 M	170 M	170 M	87.6 M	87.6 M	87.6 M	87.6 M	50.8 M	50.8 M	50.8 M	50.8 M	81 M	81 M	81 M	81 M	39.3 M	39.3 M	39.3 M	39.3 M	55.5 M	55.5 M	55.5 M	55.5 M	35.2 M	35.2 M	35.2 M	35.2 M	21.4 M	21.4 M	21.4 M	21.4 M	14.6 M	14.6 M	14.6 M	14.6 M	3.76 M	3.76 M	3.76 M	3.76 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
920 M	3.76 M	180 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	370 M	$ 20.36	-1.64 %	$ 2.57 B	USA
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	21.1 M	$ 0.81	-4.23 %	$ 4.42 M	China
Axsome Therapeutics AXSM	88.3 M	$ 164.64	-1.05 %	$ 8.19 B	USA
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
AbCellera Biologics ABCL	967 M	$ 3.7	-3.27 %	$ 1.11 B	Canada
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Burford Capital Limited BUR	1.7 B	$ 8.53	-2.35 %	$ 1.39 B	Britain
Corvus Pharmaceuticals CRVS	38.7 M	$ 18.0	0.61 %	$ 864 M	USA
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Certara CERT	1.06 B	$ 7.28	3.19 %	$ 1.17 B	USA
ARCA biopharma ABIO	382 M	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	-16.8 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	179 M	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	22.6 M	$ 26.28	-2.16 %	$ 704 M	USA
Acasti Pharma ACST	66.6 M	-	4.01 %	$ 150 M	Canada
Codexis CDXS	66.9 M	$ 1.01	-0.49 %	$ 74.1 M	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
AgeX Therapeutics AGE	5.47 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	39.9 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	-160 M	$ 3.22	-3.59 %	$ 1.15 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	1.19 B	$ 28.92	-0.96 %	$ 1.68 B	USA
Champions Oncology CSBR	3.77 M	$ 5.98	-1.48 %	$ 81.7 M	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	176 M	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	309 M	$ 3.68	-3.16 %	$ 116 M	France
Alector ALEC	30.6 M	$ 2.13	-3.62 %	$ 219 M	USA
KalVista Pharmaceuticals KALV	95.4 M	$ 15.77	-1.81 %	$ 783 M	Britain
Allena Pharmaceuticals ALNA	18.9 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	54.4 M	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	124 M	$ 4.25	2.04 %	$ 302 M	USA
AlloVir ALVR	113 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	3.36 M	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	459 M	$ 14.2	1.9 %	$ 5.89 B	Irlanda